Walter FR, Santa-Maria AR, Mszros M, Veszelka S, Dr A, Deli MA
We deliberately do not
Eli Lilly sponsored SURMOUNT-5, (NCT05822830), a Phase IIIb, open label, multi-centre, randomised clinical trial to compare the efficacy and safety of tirzepatide (Zepbound) versus semaglutide (Wegovy) in overweight or obese adults and at least one additional named weight-related comorbidity that was not T2D 24
Going straight to maintenance doses means tissue concentrations never reach therapeutic threshold
Protection against oxidative stress: Glutathione acts as a powerful antioxidant, neutralizing harmful free radicals and protecting cells from damage
It's key to know about these symptoms to handle this time well